Effect of Human Milk Oligosaccharide-based synbiotics on neurodevelopment of HIV-exposeduninfected children
Effect of Human Milk Oligosaccharide-based synbiotics on neurodevelopment of HIV-exposeduninfected children
批准号:
10712590
负责人:
Rupak Shivakoti
金额:
$35.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-11-01 至 2023-05-31
关键词:
AddressAfricanAge MonthsAnimal ModelAreaAttentionBehaviorBiologicalChildCognitionCognitiveCommunicationCountryDataData AnalysesDevelopmentEmotionalFoundationsFundingGoalsGrantGrowthHIVHIV InfectionsHIV-exposed uninfected infantHearingHumanHuman MilkImpairmentInfantInfant HealthInterventionLaboratoriesLanguageLanguage DelaysLearningLifeLinkLiteratureMemoryMethodsMorbidity - disease rateMotorObservational StudyOligosaccharidesOutcomeParentsPathway interactionsPlacebosPostpartum PeriodProbioticsQuestionnairesRandomizedRandomized, Controlled TrialsReportingResearch PersonnelResource-limited settingResourcesRodent ModelSocializationSouth AfricaSouth AfricanSpainSpeechTestingTimeVisionanimal datacognitive developmentdata modelingeffective interventionexperienceeye hand coordinationgut microbiomehigh riskhuman dataimprovedinfant gut microbiomeintervention effectmultiple datasetsneurodevelopmentparent projectrandomized trialscreeningsocialstudy populationtooltrial design
中文摘要
摘要
这是对MIGH-T MO研究(即R01HD105492,标题为:人类试验)的补充资金申请
低聚糖牛奶合生素“)正在南非进行。
这项补充研究与父母研究的目的有关,即研究干预对结果的影响。
通过关注神经发育,研究生长和发病率。神经发育是生长发育的重要组成部分
和发病率,因此与父母的研究目标相关。与儿童家长研究人群的相关性
谁是艾滋病毒暴露的未感染(CHEU),有来自包括南非在内的多个环境的数据显示
与未感染艾滋病毒的儿童(CHUU)相比,CHU的神经发育受损,以及
目前CHEU缺乏改善神经发育结果的干预措施。重要的是,动物
模型数据和来自人类的观察数据表明,某些母乳低聚糖,如2‘-
在这项研究中使用的岩藻糖基乳糖与神经发育呈正相关。因此,我们的研究
提供了一个重要的机会来测试以母乳低聚糖为基础的干预对
使用随机试验设计的CHEU神经发育。总体而言,我们假设干预将
改善CHU的神经发育。我们的发现将为合生元是否可能是一种有效的
干预措施,以减少生长缺陷和发病率,因为它们与神经发育有关,在CHU。
英文摘要
ABSTRACT
This is a request for supplement funding to the MIGH-T MO study (i.e. R01HD105492 titled: “Trial of Human
Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children”) being conducted in South Africa.
This supplement study is related to the parent study aims of studying the effect of the intervention on outcomes
of growth and morbidity, by focusing on neurodevelopment. Neurodevelopment is an important part of growth
and morbidity, thus relevant to the parent study aims. Of relevance to the parent study population of children
who are HIV-exposed uninfected (CHEU), there is data from multiple settings including South Africa that show
impaired neurodevelopment in CHEU compared to children who are HIV-unexposed uninfected (CHUU), and
an intervention to improve neurodevelopment outcomes are currently lacking for CHEU. Importantly, animal
model data and observational data from humans suggest that certain human milk oligosaccharides, such as 2’-
Fucosyllactose being used in this study, are positively associated with neurodevelopment. Thus, our study
provides an important opportunity to test the effect of the human milk oligosaccharide-based intervention on
CHEU neurodevelopment using a randomized trial design. Overall, we hypothesize that the intervention will
improve neurodevelopment in CHEU. Our findings would inform on whether the synbiotic could be an effective
intervention to reduce growth deficits and morbidity, as they relate to neurodevelopment, in CHEU.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Feasibility Study of a Powder-Based Supplement Intervention for a future Synbiotic Trial in Breastfed Children from South Africa.
针对南非母乳喂养儿童未来合生试验的粉末补充剂干预的可行性研究。
DOI:
10.21203/rs.3.rs-2842773/v1
发表时间:
2023
期刊:
Research square
影响因子:
--
作者:
[Shivakoti,Rupak, Laughton,Barbara, Shafiq,Mehr, Schoeman,Elisma, Glashoff,RichardH, Barnabas,Shaun, Fry,Samantha, Leu,Cheng-Shiun, Wang,Shuang, Bode,Lars, Aldrovandi,Grace, Kuhn,Louise, Slogrove,AmyL]
通讯作者:
Slogrove,AmyL
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children
-
批准号:10414997
-
项目类别:
-
资助金额:$64.34万
-
财政年份:2021
-
负责人:Rupak Shivakoti
-
依托单位:
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children
-
批准号:10253466
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2021
-
负责人:Rupak Shivakoti
-
依托单位:
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children
-
批准号:10671743
-
项目类别:
-
资助金额:$71.35万
-
财政年份:2021
-
负责人:Rupak Shivakoti
-
依托单位:
MATERNAL INFLAMMATION, DIET AND GUT MICROBIOME IN HIV: IMPACT ON INFANT OUTCOMES
-
批准号:9762133
-
项目类别:
-
资助金额:$24.32万
-
财政年份:2018
-
负责人:Rupak Shivakoti
-
依托单位:
Maternal inflammation, diet and gut microbiome in HIV: impact on infant outcomes
-
批准号:9335413
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2016
-
负责人:Rupak Shivakoti
-
依托单位:
海外基金